AB Corporate Bond ETF (NASDAQ:EYEG) Sees Significant Drop in Short Interest

AB Corporate Bond ETF (NASDAQ:EYEG) saw a significant drop in short interest in the month of April. As of April 30th, there was short interest totaling 250 shares, a drop of 54.5% from the April 15th total of 549 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average daily trading volume, of 99 shares, the days-to-cover ratio is presently 2.5 days.

AB Corporate Bond ETF Stock Down 0.5%

EYEG stock traded down $0.18 during trading on Friday, hitting $35.01. 13 shares of the company’s stock traded hands, compared to its average volume of 193. The firm has a market capitalization of $28.01 million, a P/E ratio of -20.84 and a beta of 0.18. The business has a fifty day simple moving average of $35.32 and a two-hundred day simple moving average of $35.72. The company has a quick ratio of 3.07, a current ratio of 3.07 and a debt-to-equity ratio of 0.01. AB Corporate Bond ETF has a 1 year low of $34.59 and a 1 year high of $36.63.

AB Corporate Bond ETF Dividend Announcement

The firm also recently disclosed a monthly dividend, which was paid on Wednesday, May 6th. Investors of record on Friday, May 1st were issued a dividend of $0.1404 per share. This represents a c) annualized dividend and a yield of 4.8%. The ex-dividend date of this dividend was Friday, May 1st. AB Corporate Bond ETF’s dividend payout ratio (DPR) is presently -103.57%.

Hedge Funds Weigh In On AB Corporate Bond ETF

Several institutional investors have recently bought and sold shares of the business. Wealth Enhancement Advisory Services LLC increased its holdings in AB Corporate Bond ETF by 32.5% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 157,702 shares of the specialty pharmaceutical company’s stock valued at $5,634,000 after buying an additional 38,685 shares during the period. Jane Street Group LLC grew its holdings in AB Corporate Bond ETF by 166.7% in the fourth quarter. Jane Street Group LLC now owns 15,741 shares of the specialty pharmaceutical company’s stock worth $563,000 after purchasing an additional 9,839 shares during the last quarter. Finally, Kestra Advisory Services LLC purchased a new position in AB Corporate Bond ETF in the fourth quarter worth $34,000. 64.16% of the stock is owned by hedge funds and other institutional investors.

About AB Corporate Bond ETF

EyeGate Pharmaceuticals, Inc is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.